[White Paper] Adapting QC Microbiology Labs for the Demands of Cell & Gene Therapies

To make good on exciting cell and gene therapy developments, quality control (QC) microbiology labs must evolve to handle more complex processes, unique scale-up needs, reduced “vein-to-vein” timelines, and demanding requirements for lot release. Fortunately, careful planning and advanced technologies can open the door to productive and safe scale-up manufacturing.

This white paper identifies key challenges now being successfully resolved via automation, with special emphasis on managing QC for the most complex cell therapies.

Fill out the form to get your copy today.